切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2015, Vol. 04 ›› Issue (01) : 22 -28. doi: 10.3877/cma.j.issn.2095-3216.2015.01.006

所属专题: 文献

专家论坛

腹膜透析相关性腹膜炎的防治
郑红光1,(), 邱辉1   
  1. 1. 110840 沈阳军区总医院肾脏病科
  • 出版日期:2015-02-28
  • 通信作者: 郑红光
  • 基金资助:
    全军十二五重点课题(BSY13C002)

Prevention and treatment of peritoneal dialysis-related peritonitis

Hongguang Zheng1,(), Hui Qiu1   

  1. 1. Department of Nephrology, General Hospital of Shenyang Military Region, Shenyang 110840, China
  • Published:2015-02-28
  • Corresponding author: Hongguang Zheng
  • About author:
    Corresponding author: Zheng Hongguang, Email:
引用本文:

郑红光, 邱辉. 腹膜透析相关性腹膜炎的防治[J]. 中华肾病研究电子杂志, 2015, 04(01): 22-28.

Hongguang Zheng, Hui Qiu. Prevention and treatment of peritoneal dialysis-related peritonitis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2015, 04(01): 22-28.

腹膜透析(PD)相关性腹膜炎是腹膜透析患者的严重并发症,降低腹膜透析相关感染的风险应该是每个PD中心的重要工作目标。对于出现感染者,应在早期进行经验性治疗,并高质量留取标本,进行有效的微生物学诊断和药敏试验,以保证抗感染治疗的准确性和有效性。腹膜透析中心应积极开展团队质量改进,包括持续进行感染监测、分析感染发生的根本原因。建立全面的腹膜炎风险评估机制,尤其要重点加强主动预防理念,在开始腹膜透析治疗的同时,对高龄、糖尿病患者等高危人群进行重点预防,有意识地加强操作正规培训和再培训、积极防止腹泻和(或)便秘以及加强隧道和出口处护理等主动预防措施,尽可能降低腹膜透析相关性腹膜炎的发生概率。

Peritoneal dialysis-associated peritonitis (PDAP) is a serious complication in peritoneal dialysis patients; it is an important goal of each PD center to reduce the risk of peritoneal dialysis-associated infection. In case of peritoneal dialysis-associated infection, empirical treatment should be given as early as possible; in the meantime, samples with high quality should be collected for effective microbiological diagnosis and drug sensitivity test so as to ensure the accuracy and effectiveness of anti-infection treatment. Each PD center should actively carry out team continuous quality improvement (CQI) plan, including continuous monitoring of infection, analyzing of the root cause of infection, establishing a mechanism for comprehensive evaluation of the risk of peritonitis, focusing on strengthening active prevention concept, laying emphasis on prevention in high-risk populations such as the olders and diabetes patients from the start of peritoneal dialysis treatment, taking a particular focus on formal training and retrain of operation, actively preventing diarrhea/constipation, and enhancing the nursing care of tunnel and exit-site, in order to reduce the probability of occurrence of PDAP as much as possible.

[1]
邱辉,王薇,张德伟,等.持续性非卧床腹膜透析患者腹膜透析相关腹膜炎病因学及病原学分析[J]. 中国实用内科杂志,2013,33(6):460-463.
[2]
Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int, 2008, 73(4): 391-398.
[3]
Lobo JV, Villar KR, de Andrade Junior MP, et al. Predictor factors of peritoneal dialysis-related peritonitis [J]. J Bras Nefrol, 2010, 32(2): 156-164.
[4]
Oygar DD, Yalin AS, Altiparmak MR, et al. Obligatory referral among other factors associated with peritonitis in peritoneal dialysis patients[J]. Nefrologia, 2011, 31(4): 435-440.
[5]
Sirivongs D, Pongskul C, Keobounma T, et al. Risk factors of first peritonitis episode in Thai CAPD patients[J]. J Med Assoc Thai, 2006,89(Suppl 2): S138-S145.
[6]
Han SH, Lee SC, Ahn SV.Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients[J].Nephrol Dial Transplant,2007,22(9): 2653-2658.
[7]
Huang JW, Hung KY, Yen CJ, et al.Systemic lupus erythematosus and peritoneal dialysis: outcomes and infectious complications[J].Perit Dial Int,2011, 21(2): 143-147.
[8]
Nessim SJ, Bargman JM, Austin PC,et al.Predictors of peritonitis in patients on peritoneal dialysis: results of a large,prospective Canadian database[J].Clin J Am Soc Nephrol, 2009, 4(7): 1195-1200.
[9]
Han SH, Lee SC, Ahn SV,et al.Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients[J].Nephrol Dial Transplant, 2007, 22(9): 2653-2658.
[10]
Piraino B, Bernardini J, Brown E, et al. ISPD: Reducing the risks of PD-related infections [J]. Perit Dial Int, 2011, 31(6): 614-630.
[11]
Li PKT, Szeto CC, Piraino B, et al. Peritoneal dialysis-related infections recommendations [J]. Perit Dial Int, 2010, 30(4): 393-423.
[12]
邱辉,洪敏,郑红光.直型与卷曲型腹膜透析导管相关并发症和导管生存率的meta分析[J].中国血液净化,2014,13(10):689-694.
[13]
周岩,李建东,俞雨生,等.直型与卷曲型鹅颈腹膜透析导管的临床应用[J].肾脏病与透析肾移植杂志,2011,20(3):240-243.
[14]
Lobo JV, Villar KR, de Andrade Junior MP,et al.Predictor factors of peritoneal dialysis-related peritonitis [J].J Bras Nefrol,2010, 32(2): 156-164.
[15]
Duranay M, Kanbay M, Turgut F,et al.Comparison of incidence of peritonitis between peritoneal dialysis solution types [J].Nephron Clin Pract, 2007, 106(1): c57-c60.
[16]
Alfa MJ, Degagne P, Olson N, et al. Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles [J]. J Clin Microbiol, 1997, 35(4): 862-866.
[17]
Sewell DL, Golper TA, Hulman PB, et al. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate [J]. Perit Dial Int, 1990, 10(1): 49-52.
[18]
Lye WC, Wong PL, Leong SO, et al. Isolation of organisms in CAPD peritonitis: a comparison of two techniques [J]. Adv Perit Dial, 1994, 10(1): 166-168.
[19]
Chow KM, Chow VC, Szeto CC, et al. Continuous ambulatory peritoneal dialysis peritonitis: broth inoculation culture versus water lysis method [J]. Nephron Clin Pract, 2007, 105(3): c121-c125.
[20]
Azap OK, Timurkaynak F, Sezer S, et al. Value of automatized blood culture systems in the diagnosis of continuous ambulatory peritoneal dialysis peritonitis [J]. Transplant Proc, 2006, 38(2): 411-412.
[21]
Zelenitsky S, Barns L, Findlay I, et al. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998 [J]. Am J Kidney Dis, 2000, 36(5): 1009-1013.
[22]
Choi P, Nemati E, Banerjee A, et al. Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization [J]. Am J Kidney Dis, 2004, 43(1): 103-111.
[23]
Lui SL, Li FK, Lo CY, et al. Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection [J]. Adv Perit Dial, 2000, 16(1): 195-197.
[24]
Mitra A, Teitelbaum I. Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines [J]. Adv Perit Dial, 2003, 19(1): 255-259.
[25]
Szeto CC, Chow KM, Wong TY, et al. Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal [J]. J Am Soc Nephrol, 2002, 13(4): 1040-1045.
[26]
Szeto CC, Kwan BC, Chow KM, et al. Recurrent and relapsing peritonitis: causative organisms and response to treatment [J]. Am J Kidney Dis, 2009, 54(4): 702-710.
[27]
Troidle L, Gorban-Brennan N, Finkelstein FO. Outcome of patients on chronic peritoneal dialysis undergoing peritoneal catheter removal because of peritonitis [J]. Adv Perit Dial, 2005, 21(1): 98-101.
[28]
Strippoli GF, Tong A, Johnson D, et al. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004, 18(4): CD004679.
[29]
Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections [J]. Perit Dial Int, 2011, 31(6): 614-630.
[30]
Campbell DJ, Johnson DW, Mudge DW, et al. Prevention of peritoneal dialysis-related infections [J]. Nephrol Dial Transplant, 2014, 10(7): 1-12.
[31]
Walker A, Bannister K, George C, et al. KHA-CARI guideline: peritonitis treatment and prophylaxis [J]. Nephrology (Carlton), 2014, 19(2): 69-71.
[32]
Strippoli GFM, Tong A, Johnson D, et al. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients [J]. Cochrane Database Syst Rev, 2004, 18(4): CD004680.
[33]
Hagen SM, Lafranca JA, Ijzermans JNM, et al. A systematic review and meta-analysis of the influence of peritoneal dialysis catheter type on complication rate and catheter survival [J]. Kidney Int, 2014, 85(4): 920-932.
[34]
Hall G, Bogan A, Dreis S, et al. New directions in peritoneal dialysis patient trainning [J]. Nephrol Nurs J, 2004, 31(2): 149-154, 159-163.
[35]
Gadola L, Poggi C, Poggio M, et al. Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients [J]. Perit Dial Int, 2013, 33(1): 38-45.
[36]
Bordin G, Casati M, Sicolo N, et al. Patient education in peritoneal dialysis: an observational study in Italy [J]. J Ren Care, 2007, 33(4): 165-171.
[37]
Russo R, Manili L, Tiraboschi G, et al. Patient re-training in peritoneal dialysis: why and when it is needed. Kidney Int, 2006, 70(103): S127-S132.
[38]
Holloway M, Mujais S, Kandert M, et al. Pediatric peritoneal dialysis training: characteristics and impact on peritonitis rates [J]. Perit Dial Int, 2001, 21(4): 401-404.
[39]
Bernardini J, Price V, Figueiredo A, et al. Peritoneal dialysis patient training [J]. Perit Dial Int, 2006, 26(6): 625-632.
[40]
Luzar M, Coles G, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis [J]. N Engl J Med, 1990, 322(8): 505-509.
[41]
Piraino B. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis. Was it effective [J]? Nephrol Dial Transplant, 2010, 25(2): 349-352.
[42]
Xu G, Tu W, Xu C. Mupirocin for preventing exit-site infection and peritonitis in patients undergoing peritoneal dialysis [J]. Nephrol Dial Transplant, 2010, 25(2): 587-592.
[1] 史博慧, 丁西萍, 王恋, 李茸, 郭萍利, 齐晶, 陈瑶, 郝娜, 任予. 乳腺癌术后皮下积液防治的最佳证据总结[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 277-284.
[2] 管佳佳, 骆杰, 傅军, 杭群, 朱磊磊, 朱冰. 预防性回肠造口对直肠前切除术后吻合口瘘及低位前切除综合征的影响分析[J]. 中华普通外科学文献(电子版), 2023, 17(05): 332-335.
[3] 徐金林, 陈征. 抗菌药物临床应用监测对腹股沟疝修补术预防用药及感染的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 720-723.
[4] 李扬, 史亚波, 涂建华, 黄长文. 胰十二指肠切除术后胰瘘发生的危险因素及预防[J]. 中华肝脏外科手术学电子杂志, 2023, 12(03): 352-355.
[5] 罗阳燕, 王少清, 高芳, 沈艳, 张万军, 李莉. 尿毒清颗粒对腹膜透析患者残余肾功能及腹透液纤连蛋白和TGF-β1水平的作用[J]. 中华肾病研究电子杂志, 2023, 12(04): 200-204.
[6] 马红叶, 刘昱, 孙婧婧, 郭利涛, 韩娟, 雷小红, 王雪, 张蕾. 基于学习型组织的多维度培训策略对ICU医护人员手卫生依从性的影响[J]. 中华重症医学电子杂志, 2023, 09(03): 245-250.
[7] 曹群群, 陈卫东, 杨秀木, 蒋召彬. 基层医务人员卫生应急素养现状及培训需求调查[J]. 中华临床医师杂志(电子版), 2023, 17(04): 375-380.
[8] 张赟辉, 罗军, 刘栗丽, 汪宏, 耿克明. 腹膜透析与血液透析对老年终末期肾病患者营养状况及炎症反应的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 419-423.
[9] 于洋, 刘孝洁, 王丽娟, 高宇晨, 丁瑶, 敖虎山. 新冠肺炎常态化条件下心肺复苏培训模式初探[J]. 中华临床医师杂志(电子版), 2023, 17(04): 483-486.
[10] 李宁, 刘言, 林慧庆. 肺移植供肺缺血再灌注损伤的机制及预防[J]. 中华胸部外科电子杂志, 2023, 10(04): 247-256.
[11] 杨丁, 牟巨伟, 高树庚. 胸外专科医师培训体系演进简述[J]. 中华胸部外科电子杂志, 2023, 10(03): 188-194.
[12] 陈雄焕, 胡培阳. 3D打印模型在骨盆骨折外固定训练中的效果研究[J]. 中华卫生应急电子杂志, 2023, 09(03): 163-165.
[13] 张许平, 刘佳成, 张舸, 杜艳姣, 李韶, 商丹丹, 王浩, 李艳, 段智慧. CYP2C19基因多态性联合血栓弹力图指导大动脉粥样硬化型非致残性缺血性脑血管事件患者抗血小板治疗的效果[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 477-481.
[14] 田丹阳, 刘小璇, 叶珊, 马新然, 樊东升, 傅瑜. 新型冠状病毒感染疫情对神经内科住院医师规范化培训的影响[J]. 中华脑血管病杂志(电子版), 2023, 17(05): 499-504.
[15] 田丹阳, 叶珊, 马新然, 李楠, 樊东升, 傅瑜. 慕课在神经内科住院医师规范化培训中应用的调查分析[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 266-270.
阅读次数
全文


摘要